Canada Pension Plan Investment Board
BMY.RT

Canada Pension Plan Investment Board’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,177,952
Closed -$813K – 1641
2020
Q4 		$813K Buy
1,177,952
+135,500
+13% +$289K ﹤0.01% 1050
2020
Q3 		$2.35M Hold
1,042,452
– – ﹤0.01% 607
2020
Q2 		$3.73M Hold
1,042,452
– – 0.01% 592
2020
Q1 		$3.96M Hold
1,042,452
– – 0.01% 564
2019
Q4 		$3.14M Buy
+1,042,452
New +$2.71M 0.01% 740

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Canada Pension Plan Investment Board's BMY.RT Position: Q1 2021 in Review

Canada Pension Plan Investment Board sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,177,952 shares — an estimated $813K sold.

Canada Pension Plan Investment Board first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $3.96M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Canada Pension Plan Investment Board reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,177,952 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $813K.
  • Canada Pension Plan Investment Board first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.96M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2021, filed 17 May 2021.